FDA-cleared profile

Versana Premier; Versana Premier Lotus; LOGIQ F

GE Medical Systems Ultrasound and Primary Care Diagnostics · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.

Clinical role
General diagnostic ultrasound acquisition, measurement, analysis, reporting, training support, and release-specific workflow automation.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: The subject of this premarket submission, Versana Premier/Versana Premier Lotus/LOGIQ F did not require clinical studies to support substantial equivalence.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: The system is a mobile console that includes an operator control panel, display monitor and transducers. The console provides digital acquisition, processing, and display capability.
  • Who uses it?Intended users: Qualified and trained healthcare professionals.
  • What does the software produce?Output: The Versana Premier/Versana Premier Lotus/LOGIQ F is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid.
  • What is its most important limitation?Key limitation: The subject of this premarket submission, Versana Premier/Versana Premier Lotus/LOGIQ F did not require clinical studies to support substantial equivalence.

Clinical takeaway. Clinical role: Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.

Evidence takeaway. Evidence from the reviewed source record: K242005 reports nonclinical system, software, probe, DICOM, cleaning, safety, and workflow verification but no clinical study. OpenFDA records Z-2029-2025 and Z-2030-2025 describe a model-specific Whizz Report defect that could carry prior-patient estimated fetal-weight data into a subsequent obstetric report.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
General diagnostic ultrasound acquisition, measurement, analysis, reporting, training support, and release-specific workflow automation.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
The system is a mobile console that includes an operator control panel, display monitor and transducers. The console provides digital acquisition, processing, and display capability.
  • Exact FDA submission
  • Checked 2026-09-19

The packet establishes console acquisition through transducers; it does not establish the dossier's worklist or bundled live, ECG, notes, and reference-information wording.

Output and clinician action
The Versana Premier/Versana Premier Lotus/LOGIQ F is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid.
  • Exact FDA submission
  • Checked 2026-09-19

This replaces the broader reports, DICOM-studies, and service-information bundle with the exact intended-use output wording.

Care setting
Hospitals and medical clinics performing general, obstetric, cardiac, vascular, musculoskeletal, and procedural ultrasound.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Qualified and trained healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

The exact indication establishes this general qualification and does not identify physicians, sonographers, or other subgroups.

Limitations
The subject of this premarket submission, Versana Premier/Versana Premier Lotus/LOGIQ F did not require clinical studies to support substantial equivalence.
  • Exact FDA submission
  • Checked 2026-09-19

The packet states the clinical-study boundary but does not establish the dossier's recall claims.

Evidence summary
K242005 reports nonclinical system, software, probe, DICOM, cleaning, safety, and workflow verification but no clinical study. OpenFDA records Z-2029-2025 and Z-2030-2025 describe a model-specific Whizz Report defect that could carry prior-patient estimated fetal-weight data into a subsequent obstetric report.
  • Exact FDA submission
  • Checked 2026-09-03

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K242005 reports nonclinical system, software, probe, DICOM, cleaning, safety, and workflow verification but no clinical study. OpenFDA records Z-2029-2025 and Z-2030-2025 describe a model-specific Whizz Report defect that could carry prior-patient estimated fetal-weight data into a subsequent obstetric report.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K242005 FDA performance package for Versana Premier; Versana Premier Lotus; LOGIQ F

  • DesignManufacturer nonclinical ultrasound-system, software, probe, DICOM, cleaning, and safety verification
  • PopulationRepresentative broad diagnostic ultrasound applications for the listed model configurations
  • Scopeexact submission
  • Tested versionVersana Premier / Versana Premier Lotus / LOGIQ F release cleared in K242005
  • IndependenceSponsor or vendor study

K242005

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
2 reviewed FDA recall records in the 2026-09-02 openFDA snapshot natively identify K242005. Read the model- and version-scoped events and confirm affected-unit and correction status with the manufacturer. FDA recall Z-2029-2025 affects specified LOGIQ F R3 systems because the Whizz Report feature could display estimated fetal-weight measurements from the previous obstetric patient, potentially producing inaccurate fetal size or growth calculations. FDA lists the recall as open and classified. FDA recall Z-2030-2025 affects specified Versana Premier R3 configurations because the Whizz Report feature could display estimated fetal-weight measurements from the previous obstetric patient, potentially producing inaccurate fetal size or growth calculations. FDA lists the recall as open and classified.
  • FDA source
  • Exact product version
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-2029-2025

Open, Classified

2025-06-26

Exact LOGIQ F R3 model match within K242005. Confirm the affected serial number and correction status; until corrected, follow the manufacturer workflow of rebooting after each obstetric examination or printing measurements directly from the worksheet instead of using Whizz Report.

recall: Z-2030-2025

Open, Classified

2025-06-26

Exact Versana Premier R3 family match within K242005. Confirm the model, serial number, and correction status; until corrected, follow the manufacturer workflow of rebooting after each obstetric examination or printing measurements directly from the worksheet instead of using Whizz Report.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: The system is a mobile console that includes an operator control panel, display monitor and transducers. The console provides digital acquisition, processing, and display capability.

    Scope: Exact FDA submission. The packet establishes console acquisition through transducers; it does not establish the dossier's worklist or bundled live, ECG, notes, and reference-information wording.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F

  2. Routing

    Source context, not route validation: DICOM workflow with configurable reporting, notes, fleet insights, remote service, and software delivery; validate worklist, report templates, patient-data isolation, probes, archive, service access, update control, and affected Whizz Report behavior.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F · GE Versana Premier

  3. AI processing

    Source context, not route validation: Mobile ultrasound console sharing a hardware and software platform across model configurations, with supported probes, options, network, remote service, and local training.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F · GE Versana Premier

  4. Returned objects

    Source context, not route validation: The Versana Premier/Versana Premier Lotus/LOGIQ F is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid.

    Scope: Exact FDA submission. This replaces the broader reports, DICOM-studies, and service-information bundle with the exact intended-use output wording.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F

  5. Viewer/worklist/report

    Unresolved route: The Versana Premier/Versana Premier Lotus/LOGIQ F is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid.

    Scope: Exact FDA submission. This replaces the broader reports, DICOM-studies, and service-information bundle with the exact intended-use output wording.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Mobile ultrasound console sharing a hardware and software platform across model configurations, with supported probes, options, network, remote service, and local training.
  • Exact FDA submission
  • Checked 2026-09-03
Integration
DICOM workflow with configurable reporting, notes, fleet insights, remote service, and software delivery; validate worklist, report templates, patient-data isolation, probes, archive, service access, update control, and affected Whizz Report behavior.
  • Exact FDA submission
  • Checked 2026-09-03
Security
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems, Ultrasound & Primary Care Diagnostics LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.

Training
Only qualified and trained physicians, sonographers, and ultrasound professionals. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: No clinical study was required for K242005. Two 2025 recalls are limited to specified LOGIQ F R3 and Versana Premier R3 units using Whizz Report; confirm model, serial number, installed correction, and current manufacturer instructions.
  • Exact FDA submission
  • Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K242005 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

DICOM workflow with configurable reporting, notes, fleet insights, remote service, and software delivery; validate worklist, report templates, patient-data isolation, probes, archive, service access, update control, and affected Whizz Report behavior.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. No clinical study was required for K242005. Two 2025 recalls are limited to specified LOGIQ F R3 and Versana Premier R3 units using Whizz Report; confirm model, serial number, installed correction, and current manufacturer instructions.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: No clinical study was required for K242005. Two 2025 recalls are limited to specified LOGIQ F R3 and Versana Premier R3 units using Whizz Report; confirm model, serial number, installed correction, and current manufacturer instructions.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242005
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-10-02
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
11Source classes checked
0Screened PubMed leads
2Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 0 PubMed and 2 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 2 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 2 FDA recall candidates were manually reviewed: 2 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 2 postmarket candidate records; 2 have been reviewed (2 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

10 sources - 3 history items

Source ledger

  1. FDA K242005: Versana Premier; Versana Premier Lotus; LOGIQ F

    U.S. Food and Drug Administration - Published 2024-10-02 - Accessed 2026-09-19

    Scope: purpose, modality, anatomy, intendedUsers, input, output, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-2029-2025: GE Healthcare LOGIQ F R3 Ultrasound System, Model/Catalog Number 5943263, diagnostic ultrasound system

    U.S. Food and Drug Administration - Published 2025-06-26 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. FDA recall Z-2030-2025: GE Healthcare Versana Ultrasound Systems, sold under the following names and Model/Catalog Numbers: 1) Versana Premier R3 VS, Model/Catalog Number 5938558; 2) Versana Premier R3 VA, Model/Catalog Number 5938559; 3) Versana Premier Lotus 4PP, Model/Catalog Number 5938560; 4) Versana Premier Lotus 5PP, Model/Catalog Number 5938561; 5) Versana Premier R3 VA Vet, Model/Catalog Number 5946387; 6) Versana Premier R3 VS Vet, Model/Catalog Number 5946481. 7) Versana Premier R3 Expert, Model/Catalog Number 5946950; 8) Versana Premier R3, Model/Catalog Number 5946951; 9) Versana Premier R3 Pro, Model/Catalog Number 5946952; 10) Versana Premier R3 Elite, Model/Catalog Number 5946953; 11) Versana Premier R3 Plus, Model/Catalog Number 5946954; 12) Versana Premier R3 Ultra, Model/Catalog Number 5946955; 13) Versana Premier R3 Max, Model/Catalog Number 5946956; 14) Versana Premier R3 Super, Model/Catalog Number 5946957; 15) Versana Premier R3 VS India, Model/Catalog Number 5948398; 16) Versana Premier R3 VA India, Model/Catalog Number 5948399; diagnostic ultrasound system

    U.S. Food and Drug Administration - Published 2025-06-26 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  5. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  6. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  7. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  8. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  9. GE Versana Premier

    GE HealthCare - Accessed 2026-09-03

    Scope: productFamilyContext, workflowRole, implementationCapabilities

  10. GE HealthCare: Product Security (portal and Cybersecurity Risk Management System)

    GE HealthCare - Accessed 2026-10-26

    Scope: security

Research history

  1. K242005 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251322

Venue; Venue Go; Venue Fit; Venue Sprint

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: Venue, Venue Go, Venue Fit, and Venue Sprint are general-purpose point-of-care ultrasound systems for trained users across broad adult, pediatric, and neonatal applications, with release-specific AI guidance and measurement functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-25
FDA-cleared K250087

Vscan Air

GE Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: Vscan Air is a wireless handheld point-of-care ultrasound system for broad adult, pediatric, and neonatal applications. K250087 adds deep-learning automatic bladder-volume measurement and compatibility with separately cleared Caption Guidance and AutoEF functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-05-01
FDA-cleared K233826

Kosmos

EchoNous, Inc.

Kosmos acquires, processes, displays, measures, and stores ultrasound with synchronized ECG and digital auscultation across cardiac, lung, abdominal, vascular, musculoskeletal, and interventional applications. Adult-only Auto EF and AI FAST are adjunct functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2024-08-29
FDA-cleared K231966

LOGIQ E10

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: LOGIQ E10 is a general-purpose diagnostic ultrasound system for broad adult and pediatric applications; K231966 adds AI-assisted renal measurements, anatomy-based preset and color suggestions, cardiac analysis, raw-data streaming, and Vscan Air CL support.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2023-11-07

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history